CervoMed Inc. Common Stock (CRVO) Stock Price

CRVOStock
$2.6571.19%52W
Market Cap$40.07M
P/E
PEG Ratio
Div yield
Beta-0.70

CRVO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-57.90%
Price vs S&P 500 (4W)-0.32%
VGM Score31.06

CRVO Earnings Surprise History

Q2 25-0.70est. -0.62
Q3 25-0.84est. -0.64
Q4 25-0.88est. -0.70
Q1 26-0.86est. -0.79
Q2 26-0.64est. -0.86

CRVO Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.07
4.08
4.08
4.08

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
CRVOCervoMed Inc. Common Stock
DDD$2.65
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About CervoMed Inc. Common Stock

CervoMed is a clinical-stage biotechnology company developing treatments for age-related neurological disorders. Its lead candidate, Neflamapimod, is designed to address synaptic dysfunction in dementia with Lewy bodies and related neurological conditions.